{"id":"calcium-glubionate","rwe":[{"pmid":"24342489","year":"2014","title":"Calcium electroporation in three cell lines: a comparison of bleomycin and calcium, calcium compounds, and pulsing conditions.","finding":"","journal":"Biochimica et biophysica acta","studyType":"Clinical Study"},{"pmid":"23026218","year":"2013","title":"Enteral calcium infusion used successfully as treatment for a patient with hereditary vitamin D resistant rickets (HVDRR) without alopecia: a novel mutation.","finding":"","journal":"Gene","studyType":"Clinical Study"},{"pmid":"22437472","year":"2012","title":"Effect of added calcium, phosphorus, and infant formula on calcium and phosphorus dialyzability in preterm donor human milk.","finding":"","journal":"Journal of pediatric gastroenterology and nutrition","studyType":"Clinical Study"},{"pmid":"19427760","year":"2010","title":"Metabolic effects of citrate- vs bicarbonate-based substitution fluid in continuous venovenous hemofiltration: a prospective sequential cohort study.","finding":"","journal":"Journal of critical care","studyType":"Clinical Study"},{"pmid":"11380487","year":"2001","title":"Effects of the selective oestrogen receptor modulator-raloxifene-on calcium and PTH secretory dynamics in women with osteoporosis.","finding":"","journal":"Clinical endocrinology","studyType":"Clinical Study"}],"tags":[{"label":"calcium glubionate","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"A12AA02","category":"atc"},{"label":"Active","category":"status"},{"label":"Hypocalcemia","category":"indication"}],"phase":"phase_2","safety":{"safetySignals":[{"llr":1080.799,"date":"","count":526,"signal":"Liver injury","source":"DrugCentral FAERS","actionTaken":"Reported 526 times (LLR=1081)"},{"llr":955.142,"date":"","count":540,"signal":"Psoriatic arthropathy","source":"DrugCentral FAERS","actionTaken":"Reported 540 times (LLR=955)"},{"llr":685.22,"date":"","count":542,"signal":"Glossodynia","source":"DrugCentral FAERS","actionTaken":"Reported 542 times (LLR=685)"},{"llr":657.599,"date":"","count":535,"signal":"Pemphigus","source":"DrugCentral FAERS","actionTaken":"Reported 535 times (LLR=658)"},{"llr":624.144,"date":"","count":547,"signal":"Systemic lupus erythematosus","source":"DrugCentral FAERS","actionTaken":"Reported 547 times (LLR=624)"},{"llr":566.408,"date":"","count":463,"signal":"Hand deformity","source":"DrugCentral FAERS","actionTaken":"Reported 463 times (LLR=566)"},{"llr":547.695,"date":"","count":551,"signal":"Arthropathy","source":"DrugCentral FAERS","actionTaken":"Reported 551 times (LLR=548)"},{"llr":519.496,"date":"","count":454,"signal":"Wound","source":"DrugCentral FAERS","actionTaken":"Reported 454 times (LLR=519)"},{"llr":516.792,"date":"","count":345,"signal":"Duodenal ulcer perforation","source":"DrugCentral FAERS","actionTaken":"Reported 345 times (LLR=517)"},{"llr":463.399,"date":"","count":529,"signal":"Rheumatoid arthritis","source":"DrugCentral FAERS","actionTaken":"Reported 529 times (LLR=463)"},{"llr":455.529,"date":"","count":306,"signal":"Fibromyalgia","source":"DrugCentral FAERS","actionTaken":"Reported 306 times (LLR=456)"},{"llr":449.58,"date":"","count":485,"signal":"Contraindicated product administered","source":"DrugCentral FAERS","actionTaken":"Reported 485 times (LLR=450)"},{"llr":431.732,"date":"","count":236,"signal":"Rheumatic fever","source":"DrugCentral FAERS","actionTaken":"Reported 236 times (LLR=432)"},{"llr":412.913,"date":"","count":309,"signal":"Helicobacter infection","source":"DrugCentral FAERS","actionTaken":"Reported 309 times (LLR=413)"},{"llr":410.73,"date":"","count":323,"signal":"Blood cholesterol increased","source":"DrugCentral FAERS","actionTaken":"Reported 323 times (LLR=411)"}],"commonSideEffects":[{"effect":"Liver injury","drugRate":"LLR 1081","severity":"serious"},{"effect":"Psoriatic arthropathy","drugRate":"LLR 955","severity":"serious"},{"effect":"Glossodynia","drugRate":"LLR 685","severity":"serious"},{"effect":"Pemphigus","drugRate":"LLR 658","severity":"serious"},{"effect":"Systemic lupus erythematosus","drugRate":"LLR 624","severity":"serious"},{"effect":"Hand deformity","drugRate":"LLR 566","severity":"serious"},{"effect":"Wound","drugRate":"LLR 519","severity":"serious"},{"effect":"Duodenal ulcer perforation","drugRate":"LLR 517","severity":"serious"},{"effect":"Rheumatoid arthritis","drugRate":"LLR 463","severity":"common"},{"effect":"Fibromyalgia","drugRate":"LLR 456","severity":"common"},{"effect":"Contraindicated product administered","drugRate":"LLR 450","severity":"common"},{"effect":"Rheumatic fever","drugRate":"LLR 432","severity":"common"},{"effect":"Helicobacter infection","drugRate":"LLR 413","severity":"common"},{"effect":"Blood cholesterol increased","drugRate":"LLR 411","severity":"common"}]},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"neo-calglucon","offLabel":[],"synonyms":["calcium glubionate","Neo-Calglucon","calcium glubionate monohydrate"],"timeline":[],"brandName":"Neo-Calglucon","ecosystem":[{"indication":"Hypocalcemia","otherDrugs":[{"name":"calcifediol","slug":"calcifediol","company":""},{"name":"calcitriol","slug":"calcitriol","company":"Validus Pharms"},{"name":"calcium acetate","slug":"calcium-acetate","company":"B Braun"},{"name":"calcium carbonate","slug":"calcium-carbonate","company":"Mcneil Cons"}],"globalPrevalence":null}],"mechanism":{"modality":"Small Molecule","drugClass":"calcium glubionate","explanation":"Think of calcium like a key that unlocks the doors to your cells, allowing them to function properly. When you have low calcium levels, your cells can't work as well as they should, leading to problems like muscle cramps and weakness. Taking Neo-Calglucon helps to restore the right balance of calcium in your body, so your cells can function normally again.","oneSentence":"Neo-Calglucon works by replenishing calcium stores in the body.","technicalDetail":"Calcium Glubionate acts as a calcium supplement, increasing serum calcium levels by providing a readily available source of calcium ions, which are then absorbed and utilized by the body to support various physiological processes."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/4842","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=CALCIUM%20GLUBIONATE","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=CALCIUM GLUBIONATE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T09:11:30.102766","biosimilars":[],"competitors":[{"drugName":"calcium phosphate","drugSlug":"calcium-phosphate","fdaApproval":"","relationship":"same-class"},{"drugName":"calcium gluconate","drugSlug":"calcium-gluconate","fdaApproval":"","patentExpiry":"Jul 25, 2037","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"calcium carbonate","drugSlug":"calcium-carbonate","fdaApproval":"2000-10-16","relationship":"same-class"},{"drugName":"calcium chloride","drugSlug":"calcium-chloride","fdaApproval":"1971-03-22","genericCount":7,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"calcium glycerylphosphate","drugSlug":"calcium-glycerylphosphate","fdaApproval":"","relationship":"same-class"},{"drugName":"calcium glucoheptonate","drugSlug":"calcium-glucoheptonate","fdaApproval":"1972-12-04","relationship":"same-class"},{"drugName":"calcium citrate","drugSlug":"calcium-citrate","fdaApproval":"","relationship":"same-class"}],"genericName":"calcium glubionate","indications":{"approved":[{"name":"Hypocalcemia","source":"DrugCentral","snomedId":5291005,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"calcium-phosphate","brandName":"calcium phosphate","genericName":"calcium phosphate","approvalYear":"","relationship":"same-class"},{"drugId":"calcium-gluconate","brandName":"calcium gluconate","genericName":"calcium gluconate","approvalYear":"","relationship":"same-class"},{"drugId":"calcium-carbonate","brandName":"calcium carbonate","genericName":"calcium carbonate","approvalYear":"2000","relationship":"same-class"},{"drugId":"calcium-chloride","brandName":"calcium chloride","genericName":"calcium chloride","approvalYear":"1971","relationship":"same-class"},{"drugId":"calcium-glycerylphosphate","brandName":"calcium glycerylphosphate","genericName":"calcium glycerylphosphate","approvalYear":"","relationship":"same-class"},{"drugId":"calcium-glucoheptonate","brandName":"calcium glucoheptonate","genericName":"calcium glucoheptonate","approvalYear":"1972","relationship":"same-class"},{"drugId":"calcium-citrate","brandName":"calcium citrate","genericName":"calcium citrate","approvalYear":"","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT07223671","phase":"PHASE1","title":"Study to Evaluate the Effect of Repotrectinib on the Drug Levels of Transporter and CYP P450 Probe Substrates in Healthy Adult Participants","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2025-12-31","conditions":["Healthy Volunteers"],"enrollment":30,"completionDate":"2026-03-19"},{"nctId":"NCT07495605","phase":"NA","title":"Effect of 1% Melatonin Gel Versus Calcium Hydroxide as an Intracanal Medicament on the Intensity of Postoperative Pain, Bacterial Load Reduction and Periapical MMP-9 Levels in Patients With Necrotic Pulp.","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2026-03-22","conditions":["Intensity of Postoperative Pain, Bacterial Load Reduction and Periapical MMP-9 Levels in Patients With Necrotic Pulp"],"enrollment":50,"completionDate":"2027-12"},{"nctId":"NCT06317662","phase":"PHASE2","title":"Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2025-06-05","conditions":["Acute Leukemia of Ambiguous Lineage","B Acute Lymphoblastic Leukemia"],"enrollment":153,"completionDate":"2028-12-31"},{"nctId":"NCT04040634","phase":"NA","title":"Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Patients With DIABETES Mellitus (OPTIMAL-DIABETES)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hospital Israelita Albert Einstein","startDate":"2019-08-08","conditions":["Diabetes Mellitus","High Blood Pressure","Cardiovascular Diseases","Cognitive Impairment"],"enrollment":9476,"completionDate":"2026-05-31"},{"nctId":"NCT03914625","phase":"PHASE3","title":"A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-07-03","conditions":["B Acute Lymphoblastic Leukemia","B Lymphoblastic Lymphoma","Down Syndrome"],"enrollment":6720,"completionDate":"2027-09-30"},{"nctId":"NCT03798678","phase":"PHASE1","title":"CB-839 HCl in Combination With Carfilzomib and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-07-08","conditions":["Recurrent Multiple Myeloma","Refractory Multiple Myeloma"],"enrollment":36,"completionDate":"2026-06-30"},{"nctId":"NCT06166849","phase":"NA","title":"Clinical Evaluation of an Experimental Remineralization Product","status":"COMPLETED","sponsor":"Ivoclar Vivadent AG","startDate":"2023-03-28","conditions":["White Spot Lesion"],"enrollment":43,"completionDate":"2025-03-11"},{"nctId":"NCT06169215","phase":"PHASE2","title":"Comparing the Combination of Selinexor-Daratumumab-Velcade-Dexamethasone (Dara-SVD) With the Usual Treatment (Dara-RVD) for High-Risk Newly Diagnosed Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-07-23","conditions":["Multiple Myeloma"],"enrollment":70,"completionDate":"2026-09-30"},{"nctId":"NCT07463807","phase":"PHASE1,PHASE2","title":"Testing the Investigational Medication Combination of Teclistamab and Pomalidomide Compared to the Usual Treatment (Carfilzomib, Pomalidomide, and Dexamethasone) for Patients With Multiple Myeloma Who Have Relapsed Shortly After Treatment","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-06-26","conditions":["Recurrent Multiple Myeloma","Refractory Multiple Myeloma"],"enrollment":162,"completionDate":"2026-08-31"},{"nctId":"NCT06899061","phase":"PHASE1","title":"Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2025-03-25","conditions":["Advanced Solid Malignancies"],"enrollment":41,"completionDate":"2026-04-30"},{"nctId":"NCT07196683","phase":"NA","title":"Regenerative Potentials of Mature Mandibular Molars With Symptomatic Irreversible Pulpitis Enhanced With Different Scaffolds","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2026-07-01","conditions":["Symptomatic Irreversible Pulpitis (SIP)"],"enrollment":36,"completionDate":"2027-11-01"},{"nctId":"NCT06867068","phase":"PHASE1","title":"Comparison of Two Intravenous Drug Combinations for Ambulatory Oral & Maxillofacial Surgery","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2016-10-04","conditions":["Anesthesia","Tooth Extraction"],"enrollment":73,"completionDate":"2024-06-10"},{"nctId":"NCT07494136","phase":"PHASE4","title":"Dose Dependent Steroid Injections","status":"NOT_YET_RECRUITING","sponsor":"University of Miami","startDate":"2026-05","conditions":["Lumbar Radiculopathy","Sciatica","Back Pain With Radiation"],"enrollment":150,"completionDate":"2027-05"},{"nctId":"NCT02997228","phase":"PHASE3","title":"Testing the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2018-01-19","conditions":["Metastatic Colorectal Adenocarcinoma","Stage IV Colorectal Cancer AJCC v7"],"enrollment":120,"completionDate":"2027-06-01"},{"nctId":"NCT07396688","phase":"NA","title":"Comparative Evaluation of the Effects of Calcium Hydroxide and BIO-C Temp Medicaments on Postoperative Pain in Patients Undergoing Endodontic Treatment: a Clinical Study","status":"RECRUITING","sponsor":"Ankara University","startDate":"2026-03-25","conditions":["Postoperative Pain","Medicaments Substances in Therapeutic Use","Calcium Hydroxide","Root Canal Retreatment"],"enrollment":60,"completionDate":"2026-04-15"},{"nctId":"NCT05564403","phase":"PHASE2","title":"Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-02-09","conditions":["Advanced Biliary Tract Carcinoma","Advanced Gallbladder Carcinoma","Advanced Intrahepatic Cholangiocarcinoma","Recurrent Biliary Tract Carcinoma","Recurrent Gallbladder Carcinoma","Recurrent Intrahepatic Cholangiocarcinoma","Stage III Distal Bile Duct Cancer AJCC v8","Stage III Gallbladder Cancer AJCC v8","Stage III Hilar Cholangiocarcinoma AJCC v8","Stage III Intrahepatic Cholangiocarcinoma AJCC v8","Stage IV Distal Bile Duct Cancer AJCC v8","Stage IV Gallbladder Cancer AJCC v8","Stage IV Hilar Cholangiocarcinoma AJCC v8","Stage IV Intrahepatic Cholangiocarcinoma AJCC v8","Unresectable Biliary Tract Carcinoma","Unresectable Gallbladder Carcinoma","Unresectable Intrahepatic Cholangiocarcinoma"],"enrollment":66,"completionDate":"2026-05-01"},{"nctId":"NCT07244991","phase":"NA","title":"Effect of MI Paste Plus™ on Streptococcus Mutans and White Spot Lesions in Fixed Orthodontics","status":"RECRUITING","sponsor":"Cardenal Herrera University","startDate":"2026-01-04","conditions":["Dental Caries","Streptococcus Mutans","Tooth Demineralization","Orthodontic Appliances, Fixed"],"enrollment":200,"completionDate":"2027-11"},{"nctId":"NCT05933499","phase":"PHASE2","title":"Effect of Tirzepatide and Bimagrumab on Body Composition, Insulin Sensitivity, and Bone in Adults With Obesity","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2025-11-05","conditions":["Obesity"],"enrollment":63,"completionDate":"2029-03-31"},{"nctId":"NCT00792948","phase":"PHASE2","title":"Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2009-09-01","conditions":["Acute Lymphoblastic Leukemia","Adult B Acute Lymphoblastic Leukemia","Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1","Adult L1 Acute Lymphoblastic Leukemia","Adult L2 Acute Lymphoblastic Leukemia","Adult T Acute Lymphoblastic Leukemia","Recurrent Adult Acute Lymphoblastic Leukemia"],"enrollment":97,"completionDate":"2027-01-06"},{"nctId":"NCT06696768","phase":"PHASE1","title":"Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2025-06-23","conditions":["Metastatic Colorectal Adenocarcinoma","Stage III Colorectal Cancer AJCC v8","Stage IV Colorectal Cancer AJCC v8","Unresectable Colorectal Adenocarcinoma"],"enrollment":24,"completionDate":"2026-12-31"},{"nctId":"NCT06948084","phase":"PHASE2","title":"Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-04-29","conditions":["Recurrent Multiple Myeloma","Refractory Multiple Myeloma"],"enrollment":80,"completionDate":"2028-02-28"},{"nctId":"NCT07105930","phase":"NA","title":"Trial to Assess Non-inferiority of an Orbital Atherectomy Only Versus a Calcium-tailored Debulking Approach","status":"RECRUITING","sponsor":"IHF GmbH - Institut für Herzinfarktforschung","startDate":"2025-10-30","conditions":["Orbital Atherectomy"],"enrollment":310,"completionDate":"2027-03"},{"nctId":"NCT06018831","phase":"NA","title":"Urine and Ultrasound Screening for Kidney Disease in Children","status":"RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2022-04-12","conditions":["Kidney Diseases","Diagnostic Techniques","Ultrasound","Urinalysis","Child, Only"],"enrollment":13000,"completionDate":"2028-02"},{"nctId":"NCT04530565","phase":"PHASE3","title":"Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-01-25","conditions":["B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1"],"enrollment":348,"completionDate":"2028-07-01"},{"nctId":"NCT04969926","phase":"","title":"Natural History Study of Parathyroid Disorders","status":"RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2021-11-30","conditions":["Parathyroid Cancer","Primary Hyperparathyroidism","Pseudohypoparathyroidism","Inheritable Bone Diseases","Multiple Endocrine Neoplasia, Type 1"],"enrollment":3000,"completionDate":"2031-01-22"},{"nctId":"NCT04847453","phase":"PHASE1","title":"Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain Amyloidosis","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2022-08-03","conditions":["Recurrent AL Amyloidosis","Refractory AL Amyloidosis"],"enrollment":24,"completionDate":"2026-06-30"},{"nctId":"NCT07444710","phase":"PHASE1","title":"Testing the Addition of an Anti-Cancer Drug, Glofitamab, to the Usual Chemotherapy Treatment (Alternating R-CHOP/R-DHAP) for Previously Untreated Mantle Cell Lymphoma","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-08-20","conditions":["Ann Arbor Stage II Mantle Cell Lymphoma","Ann Arbor Stage III Mantle Cell Lymphoma","Ann Arbor Stage IV Mantle Cell Lymphoma"],"enrollment":16,"completionDate":"2027-09-01"},{"nctId":"NCT00644228","phase":"PHASE3","title":"Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2008-07-28","conditions":["DS Stage I Multiple Myeloma","DS Stage II Multiple Myeloma","DS Stage III Multiple Myeloma"],"enrollment":525,"completionDate":"2026-09-18"},{"nctId":"NCT04835129","phase":"PHASE2","title":"Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medical College of Wisconsin","startDate":"2022-01-10","conditions":["Multiple Myeloma"],"enrollment":28,"completionDate":"2027-06-01"},{"nctId":"NCT07431866","phase":"PHASE1","title":"A Clinical Study of the Effect of MK-2828 on Rosuvastatin or Furosemide in Healthy People (MK-2828-005)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2026-03-18","conditions":["Healthy"],"enrollment":39,"completionDate":"2026-06-07"},{"nctId":"NCT05811403","phase":"NA","title":"Epigallocatechin Gallate (EGCG) as a Flushing Agent During Full Pulpotomy in Mature Permanent Molars With Irreversible Pulpitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cairo University","startDate":"2023-07-01","conditions":["Irreversible Pulpitis"],"enrollment":64,"completionDate":"2026-06-30"},{"nctId":"NCT07015242","phase":"PHASE2","title":"A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma","status":"RECRUITING","sponsor":"Juno Therapeutics, Inc., a Bristol-Myers Squibb Company","startDate":"2025-11-06","conditions":["Lymphoma"],"enrollment":65,"completionDate":"2028-12-10"},{"nctId":"NCT03994471","phase":"PHASE3","title":"Efficacy and Safety of XyloCore Peritoneal Dialysis Solution.","status":"RECRUITING","sponsor":"Iperboreal Pharma Srl","startDate":"2022-12-14","conditions":["End Stage Renal Disease"],"enrollment":170,"completionDate":"2027-04-28"},{"nctId":"NCT07491601","phase":"NA","title":"PRESS -PAR: Early Detection and PREvention of Symptomatic postSurgical hypoPARathyroidism After Thyroid Surgery\"","status":"RECRUITING","sponsor":"Nicolas Schlegel","startDate":"2025-01-08","conditions":["Postoperative Hypoparathyroidism","Postsurgical Hypoparathyroidism","Hypoparathyroidism Post-surgical"],"enrollment":336,"completionDate":"2029-12-31"},{"nctId":"NCT05519085","phase":"PHASE3","title":"A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)","status":"RECRUITING","sponsor":"Celgene","startDate":"2022-09-20","conditions":["Relapsed or Refractory Multiple Myeloma"],"enrollment":810,"completionDate":"2033-11-30"},{"nctId":"NCT06524921","phase":"NA","title":"Biodentine Pulpotomy vs Metapex Pulpectomy in Primary Molars: Clinical & Radiographic Comparison of Outcomes in Irreversible Pulpitis Cases","status":"COMPLETED","sponsor":"Mohamed Ahmed Hamdi Abo El Yamin","startDate":"2024-10-01","conditions":["Dental Caries"],"enrollment":28,"completionDate":"2025-09-15"},{"nctId":"NCT06235567","phase":"PHASE1,PHASE2","title":"Dextenza Versus Topical Steroid Eye Drops for Postoperative Management Following Corneal Crosslinking","status":"ENROLLING_BY_INVITATION","sponsor":"Maanasa Indaram, MD","startDate":"2025-04-11","conditions":["Keratoconus"],"enrollment":20,"completionDate":"2026-12"},{"nctId":"NCT04930237","phase":"","title":"RELISTOR's Effects on Opioid-Induced Constipation","status":"WITHDRAWN","sponsor":"Methodist Health System","startDate":"2021-07-01","conditions":["OIC"],"enrollment":0,"completionDate":"2022-04-22"},{"nctId":"NCT04248452","phase":"PHASE3","title":"Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body","status":"ACTIVE_NOT_RECRUITING","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"2020-05-26","conditions":["Clinical Stage IV Esophageal Adenocarcinoma AJCC v8","Clinical Stage IV Gastric Cancer AJCC v8","Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8","Clinical Stage IVA Gastric Cancer AJCC v8","Clinical Stage IVB Esophageal Adenocarcinoma AJCC v8","Clinical Stage IVB Gastric Cancer AJCC v8","Metastatic Esophageal Adenocarcinoma","Metastatic Gastric Adenocarcinoma","Oligometastatic Esophageal Adenocarcinoma","Oligometastatic Gastric Adenocarcinoma","Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8","Pathologic Stage IV Gastric Cancer AJCC v8","Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8","Pathologic Stage IVB Esophageal Adenocarcinoma AJCC v8"],"enrollment":314,"completionDate":"2028-03-31"},{"nctId":"NCT06156293","phase":"NA","title":"Prevention of Insomnia Using a Stepped Care Model in Adults","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2023-12-01","conditions":["Sleep Disturbance"],"enrollment":1016,"completionDate":"2026-12-31"},{"nctId":"NCT03969329","phase":"PHASE3","title":"A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis","status":"RECRUITING","sponsor":"Amgen","startDate":"2019-12-20","conditions":["Secondary Hyperparathyroidism"],"enrollment":24,"completionDate":"2027-06-30"},{"nctId":"NCT07488858","phase":"NA","title":"Thyroidectomy: Microscopic Versus Conventional","status":"COMPLETED","sponsor":"Shahida Islam Medical Complex","startDate":"2025-12-16","conditions":["Thyroid Cancer","Thyroid Surgeries"],"enrollment":74,"completionDate":"2026-03-15"},{"nctId":"NCT01297764","phase":"PHASE1,PHASE2","title":"A Study of Carfilzomib, Lenalidomide, Vorinostat, and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hackensack Meridian Health","startDate":"2011-04","conditions":["Multiple Myeloma"],"enrollment":17,"completionDate":"2026-07"},{"nctId":"NCT07477171","phase":"NA","title":"Mineral Trioxide Aggregate (MTA) vs Gutta-Percha for Non-Surgical Endodontic Retreatment in Teeth With Apical Lesions","status":"NOT_YET_RECRUITING","sponsor":"University of Santiago de Compostela","startDate":"2026-03","conditions":["Periapical Diseases","Root Canal Therapy","Mineral Trioxide Aggregate (MTA)"],"enrollment":58,"completionDate":"2027-04"},{"nctId":"NCT04233866","phase":"PHASE2","title":"Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread","status":"ACTIVE_NOT_RECRUITING","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"2020-08-26","conditions":["Metastatic Pancreatic Adenocarcinoma","Stage IV Pancreatic Cancer AJCC v8"],"enrollment":176,"completionDate":"2026-12-31"},{"nctId":"NCT05850091","phase":"PHASE4","title":"Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2023-12-07","conditions":["Coronary Artery Disease"],"enrollment":200,"completionDate":"2027-05-01"},{"nctId":"NCT07486570","phase":"NA","title":"Anastomotic Leakage Prevention by Endovascular Stenting of the Superior Mesenteric Artery","status":"RECRUITING","sponsor":"Medisch Spectrum Twente","startDate":"2026-02-01","conditions":["Mesenteric Vascular Disease","Colorectal Surgery","Preventive Intervention"],"enrollment":360,"completionDate":"2029-01-01"},{"nctId":"NCT07486453","phase":"PHASE1","title":"Bioequivalence Study of Sacubitril Alisartan Amlodipine Tablets","status":"NOT_YET_RECRUITING","sponsor":"Shenzhen Salubris Pharmaceuticals Co., Ltd.","startDate":"2026-03-09","conditions":["Primary Hypertension"],"enrollment":60,"completionDate":"2026-04-25"},{"nctId":"NCT02773030","phase":"PHASE1,PHASE2","title":"A Study to Determine Dose, Safety, Tolerability and Efficacy of CC-220 Monotherapy, and in Combination With Other Treatments in Subjects With Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Celgene","startDate":"2016-10-14","conditions":["Multiple Myeloma"],"enrollment":466,"completionDate":"2028-07-28"},{"nctId":"NCT07216482","phase":"PHASE3","title":"A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-11-11","conditions":["Hyperlipidemia"],"enrollment":975,"completionDate":"2027-03-01"},{"nctId":"NCT05916950","phase":"NA","title":"The THOR IDE Study","status":"RECRUITING","sponsor":"Philips Clinical & Medical Affairs Global","startDate":"2024-10-29","conditions":["Peripheral Artery Disease","Peripheral Artery Stenosis","Peripheral Artery Calcification","PAD"],"enrollment":155,"completionDate":"2027-12"},{"nctId":"NCT06997497","phase":"PHASE3","title":"A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-07-16","conditions":["Colon Adenocarcinoma","Rectal Adenocarcinoma"],"enrollment":477,"completionDate":"2030-10-27"},{"nctId":"NCT05722067","phase":"NA","title":"Improvement of Fertilization Rate and Embryo Quality by Treating Calcium Ionophore in IVF Patients: a Sibling Oocyte Control Study","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2023-01-01","conditions":["IVF","Infertility","Artificial Oocyte Activation"],"enrollment":68,"completionDate":"2025-06-30"},{"nctId":"NCT06276270","phase":"NA","title":"Multi-centre, Open-label, First-in-man Study With Mucopad HA","status":"COMPLETED","sponsor":"Contipro Pharma a.s.","startDate":"2023-12-12","conditions":["Oral Mucositis"],"enrollment":50,"completionDate":"2024-11-30"},{"nctId":"NCT06662786","phase":"PHASE3","title":"A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer","status":"RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2024-10-18","conditions":["Colorectal Neoplasms"],"enrollment":1000,"completionDate":"2032-01-30"},{"nctId":"NCT07474649","phase":"PHASE3","title":"A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events","status":"NOT_YET_RECRUITING","sponsor":"Daiichi Sankyo","startDate":"2026-06-01","conditions":["Coronary Atherosclerosis","Mixed Dyslipidemia","Hypercholesterolemia"],"enrollment":103,"completionDate":"2028-10-02"},{"nctId":"NCT04604301","phase":"NA","title":"Celtra Quatro Crown Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Michigan","startDate":"2020-09-24","conditions":["Fractured Tooth","Decayed Tooth","Unsatisfactory Restoration of Tooth"],"enrollment":48,"completionDate":"2027-11-01"},{"nctId":"NCT06782100","phase":"","title":"MRI Guided Management of Occlusive Peripheral Arterial Disease","status":"RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2024-07-01","conditions":["Peripheral Vascular Diseases"],"enrollment":175,"completionDate":"2029-06"},{"nctId":"NCT06673888","phase":"NA","title":"Assessment of Alkasite Restorative Material Versus Resin Modified Glass Ionomer in Class V Cavities: A Clinical Trial","status":"COMPLETED","sponsor":"Cairo University","startDate":"2024-12-01","conditions":["Class V Dental Caries"],"enrollment":50,"completionDate":"2025-12-01"},{"nctId":"NCT07204977","phase":"PHASE1","title":"Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Neurological Disorders and Stroke (NINDS)","startDate":"2026-02-02","conditions":["Amyotrophic Lateral Sclerosis","Motor Neuron Disease"],"enrollment":30,"completionDate":"2028-09-30"},{"nctId":"NCT07484035","phase":"NA","title":"Safety and Efficacy Evaluation of an Extensively Hydrolyzed Formula in Infants With Cow's Milk Protein Allergy (CMPA)","status":"NOT_YET_RECRUITING","sponsor":"Heilongjiang Feihe Dairy Co. Ltd.","startDate":"2026-03-05","conditions":["Cow's Milk Protein Allergy (CMPA)"],"enrollment":124,"completionDate":"2026-07-31"},{"nctId":"NCT03704350","phase":"NA","title":"Influence of Obesity on Endogenous Oxalate Synthesis","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2019-05-24","conditions":["Kidney Stone"],"enrollment":40,"completionDate":"2026-12-01"},{"nctId":"NCT07480863","phase":"PHASE2","title":"Treatment of BTKi+Hi-CVP Regimen for Previously Untreated MZL","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","startDate":"2025-10-01","conditions":["Marginal Zone Lymphoma(MZL)"],"enrollment":65,"completionDate":"2029-10-02"},{"nctId":"NCT04661540","phase":"PHASE2","title":"A Study of Auxora in Patients With Critical COVID-19 Pneumonia","status":"TERMINATED","sponsor":"CalciMedica, Inc.","startDate":"2021-03-02","conditions":["Pneumonia"],"enrollment":10,"completionDate":"2021-12-21"},{"nctId":"NCT02491632","phase":"PHASE2,PHASE3","title":"Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2015-08-13","conditions":["Advanced Malignant Neoplasm","Fatigue","Metastatic Malignant Neoplasm","Recurrent Malignant Neoplasm","Refractory Malignant Neoplasm"],"enrollment":90,"completionDate":"2026-12-31"},{"nctId":"NCT04143711","phase":"PHASE1,PHASE2","title":"Study of DF1001 in Patients With Advanced Solid Tumors","status":"COMPLETED","sponsor":"Dragonfly Therapeutics","startDate":"2019-11-11","conditions":["Solid Tumor, Adult"],"enrollment":270,"completionDate":"2025-12-05"},{"nctId":"NCT03301454","phase":"PHASE2","title":"Study of the Interest of Pursuing or Not the Chemotherapy for Patients With Metastatic Esophageal Cancer","status":"TERMINATED","sponsor":"Centre Oscar Lambret","startDate":"2018-08-20","conditions":["Esophageal Cancer, Squamous Cell"],"enrollment":15,"completionDate":"2022-07-05"},{"nctId":"NCT07239739","phase":"NA","title":"Comparing Two Medicines for Healing Jaw Bone Infections After Root Canal Treatment","status":"NOT_YET_RECRUITING","sponsor":"Faiz ur rahman","startDate":"2026-06-15","conditions":["Periapical Lesion","Periapical Periodontitis"],"enrollment":62,"completionDate":"2026-12-15"},{"nctId":"NCT03418038","phase":"PHASE2","title":"Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2018-03-23","conditions":["Clonal Cytopenia of Undetermined Significance","High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements","Recurrent Diffuse Large B-Cell Lymphoma","Recurrent Hodgkin Lymphoma","Recurrent Lymphoma","Refractory Diffuse Large B-Cell Lymphoma","Refractory Lymphoma","Chronic Myelomonocytic Leukemia"],"enrollment":80,"completionDate":"2033-11-02"},{"nctId":"NCT06013722","phase":"NA","title":"Strategy for Unstable Coronary Plaque in Patients Presenting to Emergency Department for Chest Pain Suspected of Coronary Artery Disease","status":"RECRUITING","sponsor":"Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer","startDate":"2024-03-18","conditions":["Atherosclerosis"],"enrollment":250,"completionDate":"2028-03"},{"nctId":"NCT07300280","phase":"PHASE1","title":"A Clinical Trial of Enlicitide and Rosuvastatin in Healthy Adults (MK-0616-039)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-12-29","conditions":["Healthy"],"enrollment":60,"completionDate":"2026-07-22"},{"nctId":"NCT07385781","phase":"","title":"Psychosomatic Symptoms in Patients With Myofascial Pain and Temporomandibular Joint Dysfunction","status":"NOT_YET_RECRUITING","sponsor":"Bahria University","startDate":"2026-03-01","conditions":["Psychosomatic Symptoms","Temporomandibular Disorder (TMD)"],"enrollment":300,"completionDate":"2026-08-30"},{"nctId":"NCT05272826","phase":"PHASE2","title":"Study of Iberdomide, Bortezomib, Dexamethasone With Isatuximab Added on Demand for ND-NTE MM Patients","status":"RECRUITING","sponsor":"Canadian Myeloma Research Group","startDate":"2024-12-12","conditions":["Multiple Myeloma"],"enrollment":75,"completionDate":"2031-03"},{"nctId":"NCT06207123","phase":"PHASE1,PHASE2","title":"A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2024-09-13","conditions":["Acute Leukemia","Lymphoblastic Leukemia","Lymphoblastic Lymphoma"],"enrollment":15,"completionDate":"2026-12-01"},{"nctId":"NCT06683833","phase":"PHASE4","title":"Comparison Between Egyptian MTA, Biodentine Versus Calcium Hydroxide as Indirect Pulp Capping Materials In Permanent Teeth","status":"RECRUITING","sponsor":"Cairo University","startDate":"2025-09-03","conditions":["Deep Caries","Indirect Pulp Capping","Mineral Trioxide Aggregate (MTA)","Calcium Hydroxide","Biodentine","Patient Reported Outcome Measures"],"enrollment":35,"completionDate":"2026-07-03"},{"nctId":"NCT06896669","phase":"NA","title":"Effects of Vitamin D and Calcium on Hyperglycemia and Dyslipidemia in Patients Gestational Diabetes","status":"COMPLETED","sponsor":"Riphah International University","startDate":"2025-01-28","conditions":["Diabetes Mellitus, Gestational"],"enrollment":60,"completionDate":"2026-03-05"},{"nctId":"NCT07218900","phase":"PHASE2","title":"A Study to Investigate the Effect of AZD0780 Tablets in Combination With Rosuvastatin Tablets on Low Density Lipoprotein Cholesterol Levels (LDL-C) in Adult Participants With Dyslipidaemia","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-11-13","conditions":["Dyslipidaemia"],"enrollment":76,"completionDate":"2026-09-30"},{"nctId":"NCT06918431","phase":"PHASE2","title":"Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2025-10-10","conditions":["B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative","Lymphoblastic Lymphoma"],"enrollment":53,"completionDate":"2029-03-30"},{"nctId":"NCT06712719","phase":"NA","title":"Effects of Dietary Phosphorus on Phosphorus and Calcium Whole-Body Balance and Kinetics in Moderate CKD","status":"NOT_YET_RECRUITING","sponsor":"University of Minnesota","startDate":"2026-05-01","conditions":["CKD"],"enrollment":14,"completionDate":"2027-05-28"},{"nctId":"NCT05552976","phase":"PHASE3","title":"A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bristol-Myers Squibb","startDate":"2023-01-10","conditions":["Relapsed or Refractory Multiple Myeloma"],"enrollment":525,"completionDate":"2029-07-25"},{"nctId":"NCT04789733","phase":"NA","title":"The GUARDIAN Pilot Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2021-04-27","conditions":["General Surgery"],"enrollment":80,"completionDate":"2026-12-31"},{"nctId":"NCT05081999","phase":"PHASE4","title":"De-Adoption of Beta-Blockers in Patients With Stable Ischemic Heart Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Alberta","startDate":"2023-01-30","conditions":["Stable Ischemic Heart Disease","Coronary Artery Disease","Beta-blocker Therapy"],"enrollment":59,"completionDate":"2026-12-31"},{"nctId":"NCT06469944","phase":"PHASE1,PHASE2","title":"Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-09-20","conditions":["Gastroesophageal Junction","Gastroesophageal Adenocarcinoma","Esophageal Neoplasms","Esophageal Cancer"],"enrollment":160,"completionDate":"2029-09-12"},{"nctId":"NCT07460960","phase":"PHASE2","title":"TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men","status":"RECRUITING","sponsor":"Lomonosov Moscow State University Medical Research and Educational Center","startDate":"2026-03-05","conditions":["Erectile Dysfunction Due to Arterial Disease","Atheroscleroses","Erectile Disfunction","Endothelial Dysfunction","Androgen Profile","Testosterone"],"enrollment":150,"completionDate":"2027-12"},{"nctId":"NCT07461649","phase":"NA","title":"Pharmacokinetic Study of Eicosapentaenoic Acid (EPA) and Calcium L-5-Methyltetrahydrofolate (L-5-MTHF) After Administration of CreNeuroS® CNS Fish Oil Plus Softgels in Healthy Subjects Under Fasting Conditions","status":"NOT_YET_RECRUITING","sponsor":"Sichuan Credit Pharmaceutical Co., Ltd.","startDate":"2026-03-15","conditions":["Bioavailability and Pharmacokinetics"],"enrollment":32,"completionDate":"2026-05-10"},{"nctId":"NCT05958342","phase":"PHASE2","title":"CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial","status":"RECRUITING","sponsor":"Jason Sperry","startDate":"2024-06-30","conditions":["Trauma","Hemorrhage"],"enrollment":1050,"completionDate":"2028-03"},{"nctId":"NCT05690984","phase":"PHASE2","title":"Elimination of Minimal Residual Disease After Transplant","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medical College of Wisconsin","startDate":"2023-06-26","conditions":["Multiple Myeloma"],"enrollment":30,"completionDate":"2026-07"},{"nctId":"NCT05739383","phase":"PHASE3","title":"A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2023-03-09","conditions":["Primary Prevention of Atherosclerotic Cardiovascular Disease"],"enrollment":14078,"completionDate":"2029-04-16"},{"nctId":"NCT04883242","phase":"PHASE2","title":"Isatuximab, Carfilzomib, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Washington","startDate":"2021-07-29","conditions":["Recurrent Multiple Myeloma","Refractory Multiple Myeloma"],"enrollment":30,"completionDate":"2031-12-31"},{"nctId":"NCT06348108","phase":"PHASE1","title":"Talquetamab in Combination With Iberdomide and Dexamethasone for Relapsed or Refractory Multiple Myeloma","status":"RECRUITING","sponsor":"Alfred Chung, MD","startDate":"2025-07-28","conditions":["Multiple Myeloma","Refractory Multiple Myeloma","Relapsed Multiple Myeloma"],"enrollment":32,"completionDate":"2029-07-31"},{"nctId":"NCT07471516","phase":"PHASE1,PHASE2","title":"Zoledronic Acid Treatment in Patients With Congenital Dyserythropoietic Anemia","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2026-02-25","conditions":["Congenital Dyserythropoietic Anemia (CDA)"],"enrollment":2,"completionDate":"2027-08-12"},{"nctId":"NCT05664477","phase":"PHASE2","title":"PhytoSERM to Prevent Menopause Associated Decline in Brain Metabolism and Cognition","status":"ACTIVE_NOT_RECRUITING","sponsor":"Roberta Brinton","startDate":"2024-01-10","conditions":["Menopause","Cognitive Change","Brain Disorder, Metabolic"],"enrollment":100,"completionDate":"2027-01-31"},{"nctId":"NCT06734559","phase":"NA","title":"Assessment of Masseter Muscle With Ultrasonography","status":"ACTIVE_NOT_RECRUITING","sponsor":"Harran University","startDate":"2025-01-30","conditions":["Acute Apical Periodontitis of Pulpal Origin"],"enrollment":60,"completionDate":"2026-03-11"},{"nctId":"NCT06704724","phase":"PHASE1","title":"A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pfizer","startDate":"2024-12-10","conditions":["Carcinoma, Pancreatic Ductal","Colorectal Neoplasms","Carcinoma, Non-Small-Cell Lung"],"enrollment":30,"completionDate":"2029-03-11"},{"nctId":"NCT02592317","phase":"PHASE1","title":"A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Aragon Pharmaceuticals, Inc.","startDate":"2016-02-12","conditions":["Prostatic Neoplasms, Castration-Resistant"],"enrollment":23,"completionDate":"2027-12-31"},{"nctId":"NCT07469241","phase":"PHASE2","title":"Study of MRI Guided Personal Chemoradiotherapy and Immunotherapy for Limited Advanced Esophageal Squamous Caicinoma.","status":"NOT_YET_RECRUITING","sponsor":"Fudan University","startDate":"2026-03-10","conditions":["Advanced Esophageal Squamous Cell Carcinoma","Unresectable Esophageal Squamous Cell Carcinoma"],"enrollment":50,"completionDate":"2029-06-30"},{"nctId":"NCT07469956","phase":"PHASE2","title":"Surufatinib Plus mFOLFIRINOX and PD-1 Inhibitor as the Neoadjuvant Therapy for High-risk or Borderline Resectable Pancreatic Cancer","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2026-03-31","conditions":["Pancreatic Cancer Resectable"],"enrollment":30,"completionDate":"2029-01-31"},{"nctId":"NCT01480869","phase":"PHASE3","title":"Study of Vitamin D Supplementation Tailored to Vitamin D Deficiency in Breast Cancer Patients","status":"COMPLETED","sponsor":"Institut du Cancer de Montpellier - Val d'Aurelle","startDate":"2011-07","conditions":["Breast Cancer"],"enrollment":215,"completionDate":"2014-12"},{"nctId":"NCT03249389","phase":"NA","title":"Assessing the Changes in Markers of Calcium Vitamin Metabolism of for Breast Cancer Adjuvant (CALCIOBS)","status":"COMPLETED","sponsor":"Institut du Cancer de Montpellier - Val d'Aurelle","startDate":"2015-10","conditions":["Breast Cancer"],"enrollment":146,"completionDate":"2016-09"},{"nctId":"NCT06879054","phase":"NA","title":"Lifestyle, Education, Activity, Nutrition (LEAN) Into Pregnancy","status":"NOT_YET_RECRUITING","sponsor":"Medical College of Wisconsin","startDate":"2026-07-01","conditions":["Pregnancy","Preconception Education","Preconception Care, Preconception Risk","Adverse Pregnancy Outcomes"],"enrollment":200,"completionDate":"2029-09"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NUI":"N0000179144","MMSL":"4335","NDDF":"000775","UNII":"3CF7K0SD0Q","VUID":"4020041","VANDF":"4020041","INN_ID":"2890","RXNORM":"218656","UMLSCUI":"C0061347","ChEMBL_ID":"CHEMBL2104594","KEGG_DRUG":"D03294","PUBCHEM_CID":"18940190","SNOMEDCT_US":"32445001","MESH_SUPPLEMENTAL_RECORD_UI":"C042131"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"atcClassification":{"source":"DrugCentral","atcCode":"A12AA02","allCodes":["A12AA02"]},"biosimilarFilings":[],"recentPublications":[{"date":"2014 Mar","pmid":"24342489","title":"Calcium electroporation in three cell lines: a comparison of bleomycin and calcium, calcium compounds, and pulsing conditions.","journal":"Biochimica et biophysica acta"},{"date":"2013 Jan 10","pmid":"23026218","title":"Enteral calcium infusion used successfully as treatment for a patient with hereditary vitamin D resistant rickets (HVDRR) without alopecia: a novel mutation.","journal":"Gene"},{"date":"2012 Oct","pmid":"22437472","title":"Effect of added calcium, phosphorus, and infant formula on calcium and phosphorus dialyzability in preterm donor human milk.","journal":"Journal of pediatric gastroenterology and nutrition"},{"date":"2010 Mar","pmid":"19427760","title":"Metabolic effects of citrate- vs bicarbonate-based substitution fluid in continuous venovenous hemofiltration: a prospective sequential cohort study.","journal":"Journal of critical care"},{"date":"2001 May","pmid":"11380487","title":"Effects of the selective oestrogen receptor modulator-raloxifene-on calcium and PTH secretory dynamics in women with osteoporosis.","journal":"Clinical endocrinology"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Neo-Calglucon is a small molecule calcium compound used in dental procedures, specifically in pulpotomy treatments for primary teeth. It has been studied in clinical trials for various conditions, including dentin caries and esophageal adenocarcinoma, but its primary use is in dental applications.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}